Human Gene JA700161 (uc021ptg.1) Description and Page Index
  Description: THERAPEUTIC USES OF INHIBITORS OF RTP801.
Transcript (Including UTRs)
   Position: hg19 chr10:74,035,719-74,035,753 Size: 35 Total Exon Count: 1 Strand: -


Page IndexSequence and LinksMicroarray ExpressionOther SpeciesmRNA DescriptionsOther Names
Model InformationMethods
Data last updated: 2013-06-15

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr10:74,035,719-74,035,753)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTATable SchemaExonPrimerPubMed
Stanford SOURCE

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  DL257558 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270206 - Therapeutic Uses of Inhibitors of RTP801.
JA700178 - Sequence 323 from Patent EP2402443.
DL257559 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270207 - Therapeutic Uses of Inhibitors of RTP801.
JA700179 - Sequence 324 from Patent EP2402443.
DL257556 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270204 - Therapeutic Uses of Inhibitors of RTP801.
JA700176 - Sequence 321 from Patent EP2402443.
DL257555 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270203 - Therapeutic Uses of Inhibitors of RTP801.
JA700175 - Sequence 320 from Patent EP2402443.
DL257540 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
DL257562 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270188 - Therapeutic Uses of Inhibitors of RTP801.
FU270210 - Therapeutic Uses of Inhibitors of RTP801.
JA700160 - Sequence 305 from Patent EP2402443.
JA700182 - Sequence 327 from Patent EP2402443.
DL257573 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270221 - Therapeutic Uses of Inhibitors of RTP801.
JA700193 - Sequence 338 from Patent EP2402443.
DL257576 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270224 - Therapeutic Uses of Inhibitors of RTP801.
JA700196 - Sequence 341 from Patent EP2402443.
DL257574 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270222 - Therapeutic Uses of Inhibitors of RTP801.
JA700194 - Sequence 339 from Patent EP2402443.
DL257577 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270225 - Therapeutic Uses of Inhibitors of RTP801.
JA700197 - Sequence 342 from Patent EP2402443.
DL257575 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270223 - Therapeutic Uses of Inhibitors of RTP801.
JA700195 - Sequence 340 from Patent EP2402443.
DL257541 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270189 - Therapeutic Uses of Inhibitors of RTP801.
JA700161 - Sequence 306 from Patent EP2402443.

-  Other Names for This Gene
  UCSC ID: uc021ptg.1
Representative RNA: JA700161

-  Gene Model Information
 
category: antisense nonsense-mediated-decay: no RNA accession: JA700161.1
exon count: 1CDS single in 3' UTR: no RNA size: 21
ORF size: 0CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 0.00frame shift in genome: no % Coverage: 85.71
has start codon: no stop codon in genome: no # of Alignments: 1
has end codon: no retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.